Optimization and Improvement of the Quality Standards of Mongolian Medicine Formulation Yurijel-13

  • HUANG Yixiao ,
  • CHEN Peng ,
  • ZHAO Longshan ,
  • GUO Ye ,
  • GUO Jingjing ,
  • AN Ming
Expand
  • 1. School of Pharmacy, Baotou Medical College, Baotou 014040, China;
    2. School of Pharmacy, Shenyang Pharmaceutical University

Received date: 2025-02-19

  Online published: 2025-07-09

Abstract

Objective: To optimize and enhance the quality standard of Yurijle-13 pill, a Mongolian medicinal preparation. Methods: :Microscopic identification was carried out on the powder of the formula encompassing Aucklandia lappa Decne, Gardenia jasminoides Ellis, Chrysanthemum morifolium Ramat, Punica granatum L, and Piper longum L in Yurijle-13 pill. Thin Layer Chromatography (TLC) was established for the identification of Aucklandia lappa Decne, Gardenia jasminoides Ellis, and Salvia miltiorrhiza Bge in Yurijle-13 pill. High Performance Liquid Chromatography (HPLC) was developed to concurrently determine the contents of the principal ingredient, Costunolide (CL), and Dehydrocostus lactone (DL) in the Aucklandia lappa Decne of Yurijle-13 pill by using a SinoPak SP analytical column (4.6 mm×250 mm, 5 μm), with a mixture of methanol and water (6535) as the mobile phase, a flow rate of 1.0 mL/min, a column temperature of 30 ℃, and a detection wavelength of 225 nm. Results: :The microscopic characteristics of the powder of Aucklandia lappa Decne, Gardenia jasminoides Ellis, Chrysanthemum morifolium Ramat, Punica granatum L, and Piper longum L in Yurijle-13 pill were distinct. Aucklandia lappa Decne, Gardenia jasminoides Ellis, and Salvia miltiorrhiza Bge demonstrated strong specificity in TLC qualitative identification. The linear regression equation for CL was y=315.83x-3.9247 (within the concentration range of 0.0051 to 0.2504 mg/mL), and that for DL was y=276.65x-5.5702 (within the concentration range of 0.0497 to 0.2494 mg/mL). The RSDs for the tests of precision, stability, and reproducibility were 1.13% and 1.17%, 3.43% and 3.04%, and 0.65% and 0.26%, respectively, and the average recovery rates were within the specified range (85.0% to 110.0%). Conclusion: :Compared with the Inner Mongolia Autonomous Region hospital preparation approved, the method for identification and content determination of Yourile-13 pill established in this study not only increase the types of identified medicinal materials and the main components of the drug, but also has the advantages of convenient operation, strong specificity and good repeatability, which is suitable for the quality control of Yourile-13 pill.

Cite this article

HUANG Yixiao , CHEN Peng , ZHAO Longshan , GUO Ye , GUO Jingjing , AN Ming . Optimization and Improvement of the Quality Standards of Mongolian Medicine Formulation Yurijel-13[J]. Journal of Baotou Medical College, 2025 , 41(6) : 31 -36 . DOI: 10.16833/j.cnki.jbmc.2025.06.007

References

[1] 内蒙古医学院中医系.蒙医药选编[M].呼和浩特: 内蒙古人民出版, 1974: 46-47.
[2] 李玉华, 姜楠.HPLC法测定蒙成药优日勒-13中栀子苷的含量[J].中国民族民间医药, 2021, 30(4): 49-51.
[3] 赵梅花, 李梅, 乌吉木, 等.优日勒-13联合奥美拉唑治疗老年慢性浅表性胃炎及对患者胃肠激素水平、T淋巴细胞的影响分析[J].临床和实验医学杂志, 2018, 17(15): 1641-1644.
[4] 内蒙古卫生厅.内蒙古蒙成药标准1988年补充本[M].呼和浩特: 内蒙古人民出版社, 1988: 19.
[5] 罗杨, 刘薇.木香及其有效成分抗癌作用的研究进展[J].中国民族民间医药, 2023, 32(11): 65-69.
[6] 杨超, 陈强威, 叶彬.去氢木香内酯抗肿瘤作用机制研究进展[J].食品与药品, 2024, 26(03): 290-294.
[7] 刘丹, 刘明, 金良友, 等.木香烃内酯抗肿瘤活性研究进展[J].中国临床药理学与治疗学, 2023, 28(10): 1168-1176.
[8] 国家药典委员会.中国药典(一部): 2020年版[M].北京: 中国医药科技出版社, 2020: 230.
[9] 国家药典委员会.中国药典(一部): 2020年版[M].北京: 中国医药科技出版社, 2020: 63, 259, 77.
Outlines

/